AlloVir Inc (NASDAQ: ALVR) is 14.84% higher on its value in year-to-date trading and has touched a low of $0.58 and a high of $3.45 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ALVR stock was last observed hovering at around $0.75 in the last trading session, with the day’s gains setting it 0.03%.
Currently trading at $0.78, the stock is 4.21% and 3.33% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.93 million and changing 4.09% at the moment leaves the stock -15.72% off its SMA200. ALVR registered -74.32% loss for a year compared to 6-month gain of 8.40%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a -0.70% loss in the last 1 month and extending the period to 3 months gives it a 3.13%, and is 1.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.74% over the week and 5.89% over the month.
AlloVir Inc (ALVR) has around 112 employees, a market worth around $90.06M and $0.00M in sales. Distance from 52-week low is 34.60% and -77.37% from its 52-week high. The company has generated returns on investments over the last 12 months (-109.11%).
The EPS is expected to grow by 72.86% this year.
AlloVir Inc (ALVR) Top Institutional Holders
93.0 institutions hold shares in AlloVir Inc (ALVR), with institutional investors hold 82.69% of the company’s shares. The shares outstanding are 113.97M, and float is at 55.53M with Short Float at 10.30%. Institutions hold 41.86% of the Float.
The top institutional shareholder in the company is ECOR1 CAPITAL, LLC with over 11.29 million shares valued at $8.17 million. The investor’s holdings represent 9.8479% of the ALVR Shares outstanding. As of 2024-06-30, the second largest holder is OCTAGON CAPITAL ADVISORS LP with 9.8 million shares valued at $7.09 million to account for 8.5447 of the shares outstanding. The other top investors are ARTAL GROUP S.A. which holds 6.6 million shares representing 5.7521% and valued at over $4.77 million, while MILLENNIUM MANAGEMENT LLC holds 2.8736 of the shares totaling 3.3 million with a market value of $2.38 million.
AlloVir Inc (ALVR) Insider Activity
The most recent transaction is an insider sale by Brainard Diana, the company’s Chief Executive Officer. SEC filings show that Brainard Diana sold 5,390 shares of the company’s common stock on Aug 20 ’24 at a price of $0.74 per share for a total of $3996.0. Following the sale, the insider now owns 0.75 million shares.
Still, SEC filings show that on Aug 19 ’24, Miller Edward (General Counsel) disposed off 422 shares at an average price of $0.76 for $321.0. The insider now directly holds 215,981 shares of AlloVir Inc (ALVR).
